Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
RGNX
#2557
REGENXBIO Inc.
9.040
0
+8.00%
Sector:
Base:
Profit Currency:
Daily Range
Year Range
Daily Change
+8.00%
Monthly Change
-5.88%
6 month change
-32.69%
Year Change
-32.69%
Previous Close
8.370
0
Open
9.040
0
Bid
Ask
Low
9.040
0
High
9.040
0
Volume
78
Markets
US Stock Market
Healthcare
RGNX
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
News
Stifel comments on uniQure shares after FDA commissioner remarks
Uniqure Plummets As FDA's Marty Makary Disparages Rejected Rare Disease Drug
Regenxbio (RGNX) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
Is the SPDR S&P Biotech ETF (XBI) a ‘Strong Buy’ Right Now? - TipRanks.com
REGENXBIO: Cautiously Bullish After FDA Setbacks (NASDAQ:RGNX)
Regenxbio stock price target lowered to $32 at H.C. Wainwright after FDA rejection
Intel, Wells Fargo among market cap stock movers on Tuesday
Netflix and Oracle among market cap stock movers on Tuesday
Regenxbio stock price target lowered by Goldman Sachs on RGX-121 setback
After-hours movers: ON Semiconductor, Credo, Upwork, Regenxbio, and more
REGENXBIO stock falls after FDA rejects gene therapy for Hunter syndrome
Regenxbio (RGNX) Soars 5.4%: Is Further Upside Left in the Stock?